Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2021 | Dec 2020 | Dec 2019 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 24.02B | 24.45B | 29.08B | 22.16B | 21.45B | 21.05B |
Gross Profit | 13.50B | 15.22B | 12.74B | 13.41B | 12.79B | 12.03B |
EBITDA | 8.28B | 17.54B | 16.26B | 16.09B | 15.39B | 14.54B |
Net Income | 12.38B | 12.93B | 11.85B | 11.43B | 10.84B | 10.13B |
Balance Sheet | ||||||
Total Assets | 342.89B | 333.31B | 336.33B | 330.06B | 309.41B | 308.82B |
Cash, Cash Equivalents and Short-Term Investments | 12.13B | 12.86B | 17.62B | 8.10B | 6.52B | 14.11B |
Total Debt | 137.70B | 127.70B | 130.10B | 123.40B | 116.90B | 112.90B |
Total Liabilities | 167.31B | 157.66B | 161.94B | 155.61B | 150.46B | 147.24B |
Stockholders Equity | 175.58B | 175.65B | 174.39B | 174.45B | 158.95B | 161.58B |
Cash Flow | ||||||
Free Cash Flow | 5.38B | 14.23B | 5.37B | -8.01B | 7.14B | -15.11B |
Operating Cash Flow | 17.12B | 21.14B | 21.15B | 15.02B | 15.41B | 19.19B |
Investing Cash Flow | -15.55B | -7.78B | -16.36B | -23.78B | -9.37B | -34.81B |
Financing Cash Flow | -1.92B | -14.07B | -5.13B | 10.51B | -9.48B | 19.00B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | ¥189.48B | 20.14 | ― | 4.81% | 13.33% | 8.96% | |
74 Outperform | ¥170.12B | 15.63 | ― | 4.96% | 50.47% | 26.45% | |
72 Outperform | ¥239.12B | 19.31 | ― | 4.93% | 4.11% | 2.05% | |
67 Neutral | ¥274.23B | 22.29 | ― | 4.32% | -0.15% | -2.63% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
64 Neutral | ¥202.45B | 22.65 | ― | 4.33% | 13.38% | -6.44% |